Rebecca C. Woodruff PhD , Xin Tong MPH , Adam S. Vaughan PhD , Nilay S. Shah MD , Sadiya S. Khan MD, MSc , Omoye E. Imoisili MD , Fleetwood V. Loustalot PhD , Essi M. Havor PhD , Susan A. Carlson PhD
{"title":"Trends in Mortality Rates for Cardiovascular Disease Subtypes Among Adults, 2010–2023","authors":"Rebecca C. Woodruff PhD , Xin Tong MPH , Adam S. Vaughan PhD , Nilay S. Shah MD , Sadiya S. Khan MD, MSc , Omoye E. Imoisili MD , Fleetwood V. Loustalot PhD , Essi M. Havor PhD , Susan A. Carlson PhD","doi":"10.1016/j.amepre.2025.108119","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Cardiovascular disease mortality rates, which had been declining in the decade before the COVID-19 pandemic, increased in 2020 and remained elevated through 2022. Understanding whether trends in mortality rates from 2010 to 2023 varied by cardiovascular disease subtypes could help focus prevention and clinical management.</div></div><div><h3>Methods</h3><div>Annual age-standardized mortality rates per 100,000 for U.S. adults were calculated in 2025 using National Vital Statistics System death counts from 2010 to 2023. Deaths with cardiovascular disease listed as the underlying cause of death were classified into 8 major cardiovascular disease subtypes. Temporal trends from 2010 to 2023 were evaluated using average annual percentage change.</div></div><div><h3>Results</h3><div>In 2023, age-standardized mortality rates for cardiovascular disease subtypes were highest for ischemic heart disease (117.9 deaths per 100,000), followed by hypertensive disease (111.2), heart failure (82.1), cerebrovascular disease (65.7), arrhythmia (48.4), valvular heart disease (13.0), pulmonary heart disease (11.9), and cardiomyopathy (9.4). From 2010 to 2023, age-standardized mortality rates significantly declined for ischemic heart disease (average annual percentage change= −2.21) and cardiomyopathy (average annual percentage change= −3.00) and increased for hypertensive disease (average annual percentage change=2.52), arrhythmia (average annual percentage change=1.14), and pulmonary heart disease (average annual percentage change=1.38). Although the overall trend was not significant, age-standardized mortality rates were higher in 2023 than in 2010 for heart failure and lower for cerebrovascular disease and valvular heart disease.</div></div><div><h3>Conclusions</h3><div>From 2010 to 2023, mortality rates improved for ischemic heart disease and cardiomyopathy but worsened for hypertensive disease, arrhythmia, and pulmonary heart disease. These results signal a need to focus prevention and clinical management efforts to target the growing burden of cardiovascular disease subtypes.</div></div>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":"70 1","pages":"Article 108119"},"PeriodicalIF":4.5000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Preventive Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0749379725005872","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Cardiovascular disease mortality rates, which had been declining in the decade before the COVID-19 pandemic, increased in 2020 and remained elevated through 2022. Understanding whether trends in mortality rates from 2010 to 2023 varied by cardiovascular disease subtypes could help focus prevention and clinical management.
Methods
Annual age-standardized mortality rates per 100,000 for U.S. adults were calculated in 2025 using National Vital Statistics System death counts from 2010 to 2023. Deaths with cardiovascular disease listed as the underlying cause of death were classified into 8 major cardiovascular disease subtypes. Temporal trends from 2010 to 2023 were evaluated using average annual percentage change.
Results
In 2023, age-standardized mortality rates for cardiovascular disease subtypes were highest for ischemic heart disease (117.9 deaths per 100,000), followed by hypertensive disease (111.2), heart failure (82.1), cerebrovascular disease (65.7), arrhythmia (48.4), valvular heart disease (13.0), pulmonary heart disease (11.9), and cardiomyopathy (9.4). From 2010 to 2023, age-standardized mortality rates significantly declined for ischemic heart disease (average annual percentage change= −2.21) and cardiomyopathy (average annual percentage change= −3.00) and increased for hypertensive disease (average annual percentage change=2.52), arrhythmia (average annual percentage change=1.14), and pulmonary heart disease (average annual percentage change=1.38). Although the overall trend was not significant, age-standardized mortality rates were higher in 2023 than in 2010 for heart failure and lower for cerebrovascular disease and valvular heart disease.
Conclusions
From 2010 to 2023, mortality rates improved for ischemic heart disease and cardiomyopathy but worsened for hypertensive disease, arrhythmia, and pulmonary heart disease. These results signal a need to focus prevention and clinical management efforts to target the growing burden of cardiovascular disease subtypes.
期刊介绍:
The American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health.
Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women''s health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.